Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AFL Stock Forecast 2025-2026
$114.34
Current Price
$59.93B
Market Cap
Buy 3
Hold 8
Sell 2
Wall St Analyst Ratings
Distance to AFL Price Targets
+11.1%
To High Target of $127.00
-2.9%
To Median Target of $111.00
-12.5%
To Low Target of $100.00
AFL Price Momentum
+0.2%
1 Week Change
+4.1%
1 Month Change
+2.7%
1 Year Change
+10.5%
Year-to-Date Change
-1.3%
From 52W High of $115.84
+17.9%
From 52W Low of $96.95
📊 TOP ANALYST CALLS
Did AFL Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Aflac is one of their latest high-conviction picks.
Latest AFL Stock Price Targets & Analyst Predictions
Based on our analysis of 22 Wall Street analysts, AFL has a neutral consensus with a median price target of $111.00 (ranging from $100.00 to $127.00). The overall analyst rating is Buy (6.2/10). Currently trading at $114.34, the median forecast implies a -2.9% downside. This outlook is supported by 3 Buy, 8 Hold, and 2 Sell ratings.
Conversely, the most conservative target is provided by Jimmy Bhullar at JP Morgan, suggesting a 12.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AFL Analyst Ratings
3
Buy
8
Hold
2
Sell
AFL Price Target Range
Low
$100.00
Average
$111.00
High
$127.00
Current: $114.34
Latest AFL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AFL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 7, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $109.00 |
| Nov 7, 2025 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $111.00 |
| Nov 5, 2025 | JP Morgan | Jimmy Bhullar | Neutral | Maintains | $101.00 |
| Nov 5, 2025 | Barclays | Alex Scott | Underweight | Maintains | $104.00 |
| Oct 9, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $110.00 |
| Oct 9, 2025 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $110.00 |
| Oct 8, 2025 | Barclays | Alex Scott | Underweight | Maintains | $102.00 |
| Aug 18, 2025 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $113.00 |
| Aug 15, 2025 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $106.00 |
| Aug 11, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $108.00 |
| Aug 11, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $107.00 |
| Aug 6, 2025 | UBS | Brian Meredith | Neutral | Maintains | $111.00 |
| Jul 14, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Jul 10, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $105.00 |
| Jul 8, 2025 | JP Morgan | Jimmy Bhullar | Neutral | Maintains | $100.00 |
| Jul 7, 2025 | Barclays | Alex Scott | Underweight | Maintains | $98.00 |
| May 29, 2025 | Raymond James | Wilma Burdis | Outperform | Maintains | $110.00 |
| May 19, 2025 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $105.00 |
| May 7, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $106.00 |
| May 6, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $103.00 |
Aflac Inc. (AFL) Competitors
The following stocks are similar to Aflac based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Aflac Inc. (AFL) Financial Data
Aflac Inc. has a market capitalization of $59.93B with a P/E ratio of 15.1x. The company generates $17.70B in trailing twelve-month revenue with a 23.6% profit margin.
Revenue growth is +60.7% quarter-over-quarter, while maintaining an operating margin of +43.3% and return on equity of +15.6%.
Valuation Metrics
Market Cap
$59.93B
Enterprise Value
$65.49B
P/E Ratio
15.1x
PEG Ratio
0.0x
Price/Sales
3.4x
Growth & Margins
Revenue Growth (YoY)
+60.7%
Gross Margin
N/A
Operating Margin
+43.3%
Net Margin
+23.6%
EPS Growth
+57.9%
Financial Health
Cash/Price Ratio
+15.2%
Current Ratio
1.1x
Debt/Equity
50.0x
ROE
+15.6%
ROA
+2.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Aflac Inc. (AFL) Business Model
About Aflac Inc.
What They Do
Provider of life and health insurance.
Business Model
Aflac generates revenue through supplemental health and life insurance policies in Japan and the United States, catering to both individual and corporate clients. Its extensive distribution network and innovative insurance products, particularly in cancer and living benefits, contribute to its profitability.
Additional Information
The company operates through subsidiaries that manage investments and multi-line insurance services, enhancing its market presence. Aflac is recognized for its stability and scale, frequently ranking among the largest global insurers by market capitalization.
Company Information
Sector
Financial Services
Industry
Insurance - Life
Employees
12,694
CEO
Mr. Daniel Paul Amos
Country
United States
IPO Year
1984
Website
www.aflac.comAflac Inc. (AFL) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
Globe Life is set to grow on growing premiums, rising investment income, and disciplined capital deployment.
Nov 13, 2025
By Zacks Equity Research
Analyst Blog
ProAssurance Q3 Earnings Miss Estimates on Weak Specialty P&C Unit
PRA misses Q3 EPS estimates as weak Specialty P&C results and higher costs outweigh gains in investment income.
Nov 07, 2025
By Zacks Equity Research
Analyst Blog
Aflac Q3 Earnings Beat Estimates on Strong Group Life Sales
AFL tops Q3 estimates with EPS up 15.3% year over year and revenues surging 60.7%, driven by strong cancer insurance product sales and robust U.S. segment performance.
Nov 05, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Aflac Incorporated (NYSE: AFL) declared a Q1 dividend of $0.61 per share, payable on March 2, 2026, to shareholders recorded by February 18, 2026.
Why It Matters
Aflac's dividend declaration signals financial stability and profitability, potentially attracting income-focused investors and boosting stock demand.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
AFL has raised its dividend for the 43rd consecutive year, supported by a strong balance sheet and robust growth in the U.S. market.
Why It Matters
AFL's 43rd consecutive dividend increase signals financial stability and strong performance, likely boosting investor confidence and attracting income-focused buyers.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
ADP's board approved a $0.16 increase in its quarterly cash dividend, raising the annual rate to $6.80 per share, marking the 51st consecutive year of dividend increases.
Why It Matters
ADP's 51st consecutive annual dividend increase reflects strong financial health and commitment to returning capital, potentially boosting investor confidence and stock attractiveness.
Source: Forbes
Market Sentiment:
Positive
Quick Summary
Dividend stocks vary widely, indicating that investors should consider individual financial situations and preferences rather than seeking a universal approach.
Why It Matters
The lack of a "one-size-fits-all" approach to dividend stocks highlights the need for tailored investment strategies, affecting portfolio risk and income generation.
Source: 24/7 Wall Street
Market Sentiment:
Positive
Quick Summary
Aflac exceeded Wall Street expectations for Q3 profit and revenue, attributed to investment gains and increased premium growth in its U.S. division.
Why It Matters
Aflac's strong Q3 results indicate robust performance and growth potential, suggesting increased profitability and stability, which can boost investor confidence and stock valuation.
Source: Reuters
Market Sentiment:
Positive
Quick Summary
Aflac Incorporated (AFL) will hold its Q3 2025 earnings call on November 5, 2025, at 8:00 AM EST, featuring key executives including the CEO and CFO.
Why It Matters
Aflac's Q3 earnings call will provide insights into financial performance, strategies, and market outlook, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About AFL Stock
What is Aflac Inc.'s (AFL) stock forecast for 2026?
Based on our analysis of 22 Wall Street analysts, Aflac Inc. (AFL) has a median price target of $111.00. The highest price target is $127.00 and the lowest is $100.00.
Is AFL stock a good investment in 2026?
According to current analyst ratings, AFL has 3 Buy ratings, 8 Hold ratings, and 2 Sell ratings. The stock is currently trading at $114.34. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AFL stock?
Wall Street analysts predict AFL stock could reach $111.00 in the next 12 months. This represents a -2.9% decrease from the current price of $114.34. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Aflac Inc.'s business model?
Aflac generates revenue through supplemental health and life insurance policies in Japan and the United States, catering to both individual and corporate clients. Its extensive distribution network and innovative insurance products, particularly in cancer and living benefits, contribute to its profitability.
What is the highest forecasted price for AFL Aflac Inc.?
The highest price target for AFL is $127.00 from at , which represents a 11.1% increase from the current price of $114.34.
What is the lowest forecasted price for AFL Aflac Inc.?
The lowest price target for AFL is $100.00 from Jimmy Bhullar at JP Morgan, which represents a -12.5% decrease from the current price of $114.34.
What is the overall AFL consensus from analysts for Aflac Inc.?
The overall analyst consensus for AFL is neutral. Out of 22 Wall Street analysts, 3 rate it as Buy, 8 as Hold, and 2 as Sell, with a median price target of $111.00.
How accurate are AFL stock price projections?
Stock price projections, including those for Aflac Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 15, 2025 9:21 PM UTC